Registry of biomedical companies:
[3] [4] [7] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 507 active entries
P.O. Box 1753
85706 Unterschleißheim
Germany Phone: +49-89-32141960
Fax: +49-89-32141959
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Description:
I.Proprietary technologies:
A)magnetic beads, immobilised ligands, bead handling instrumentation B) reverse transcriptase assay kit (DPA/US patents - approved) C)natural resource of antiviral compounds with multitarget inhibitory properties against retroviruses (e.g. HIV-1), other viruses (e.g. Hepatitis, Herpes), bacteria (Gram+/-)and fungi(e.g. Candida) and systemic therapeutic potential in complex infectious disease e.g. AIDS, Hepatitis (PCT/DPA patent application) II.Proprietary products:
A) Laboratory kits for quantitation of retroviruses by sample preparation and virus associated reverse transcriptase (US patent- approved)
a) Screen RTA-Kit - drug screening of compound libraries
b) Research RTA-Kit - quantit.virus monitoring in virus research (vaccine, genetherapy, viral vectors other)
c) Viral Load RTA-Kit - quantit.HIV & phenotypical resistence monitoring along AIDS therapy
d) BioSafety RTA-Kit - safety testing for retroviruses whithin bio-materials in transfusion- transplantation medicine, bio-pharmaceuticals, bio-cosmetics, bio-genetic nutrition B) Laboratory instrumentation for
a) magnetic bead handling whithin 96 well microplates by manual and automatic devices (separators, washer)
b) HSTC-high speed & throughput centrifugation and sample preparation (centrifuges, rotors, adaptors, tubes) C)Laboratory reagents for biomedical research only:
a)CD4-receptor reagents, HIV-gp120 specific antibodies
b)PERV-porcine endogenous retrovirus- antigens, specific antibodies- for D)Retro-Vital: natural food supplement for complementary treatment of HIV-1 infected patients along anti-retroviral therapy (HAART, other) III. Contract Services:
a) antiviral drug screening by cellular toxicity & infectivity systems, biochemical systems,animal models - entry inhibition, reverse transcription, protease action b) biosafety testing for retroviral safety/contamination of cell cultures, biomaterials, biopharmaceuticals etc. c) production of biopharmaceuticals e.g. retroviruses, antigens, vaccines from cell cultures d) corporate consulting - financing, founding, growth, consolidation e) technology & IP consulting
Selected Categories:
Last update of this entry: September 17, 2019
|